Preclinical studies of the Chinese Herbal Medicine formulation PHY906 (KD018) as a potential adjunct to radiation therapy
- 3 September 2012
- journal article
- Published by Taylor & Francis Ltd in International Journal of Radiation Biology
- Vol. 89 (1), 16-25
- https://doi.org/10.3109/09553002.2012.717733
Abstract
Objective: Abdominal and pelvic radiotherapy is limited by the radiosensitivity of the small and large intestine. PHY906 (KD018), a state-of-the-art, well defined adaptation of a traditional Chinese medicine, decreased intestinal injury from chemotherapy in preclinical studies and is in clinical trials with chemotherapy. This project assessed whether PHY906 would also reduce intestinal injury from abdominal irradiation in mice. Materials and methods: BALB/c mice received whole-abdomen irradiation (2 Gy/day) ± PHY906 by oral gavage twice daily for 4 days. Intestinal injury was assayed by physiological observations and histological studies. Effects of PHY906 on EMT6 mouse mammary tumors were assayed in tumor growth studies. Results: PHY906 decreased toxicity from fractionated abdominal irradiation. Radiation alone produced marked blunting and loss of villi, crypt hyperplasia and irregular crypt morphology, which were reduced by PHY906. The radiation-induced reduction in viable crypt numbers was also mitigated by PHY906. PHY906 did not alter radiation-induced weight loss, but resulted in more rapid recovery. PHY906 did not alter tumor growth, local invasion or metastatic spread and did not protect tumors from growth delays produced by single-dose or fractionated irradiation. Conclusion: In this mouse model, PHY906 (KD018) decreased the toxicity of abdominal irradiation without protecting tumors and thereby increased the therapeutic ratio.Keywords
This publication has 35 references indexed in Scilit:
- Preclinical evaluation of Laromustine for use in combination with radiation therapy in the treatment of solid tumorsInternational Journal of Radiation Biology, 2011
- Subclinical vitamin A deficiency does not increase development of tumors in irradiated or unirradiated lungsExperimental Biology and Medicine, 2011
- Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironmentBMC Medical Genomics, 2011
- Identification of chemicals and their metabolites from PHY906, a Chinese medicine formulation, in the plasma of a patient treated with irinotecan and PHY906 using liquid chromatography/tandem mass spectrometry (LC/MS/MS)Journal of Chromatography A, 2010
- A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqin Tang (HQT) and PHY906Chinese Medicine, 2010
- Are Herbal Medicines Ripe for the Cancer Clinic?Science Translational Medicine, 2010
- The Four-Herb Chinese Medicine PHY906 Reduces Chemotherapy-Induced Gastrointestinal ToxicityScience Translational Medicine, 2010
- Liquid chromatography/mass spectrometry analysis of PHY906, a Chinese medicine formulation for cancer therapyRapid Communications in Mass Spectrometry, 2007
- In Vivo Analysis and Spatial Profiling of Phytochemicals in Herbal Tissue by Matrix-Assisted Laser Desorption/Ionization Mass SpectrometryAnalytical Chemistry, 2007
- Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohoshBreast Cancer Research and Treatment, 2005